On this page: Medical devices reforms | IVD medical devices reforms

Medical devices reforms

Reclassification of surgical mesh devices

• Reclassification of surgical mesh devices
  From 1 December 2018, all new surgical mesh devices (including urogynaecological mesh devices) seeking approval from the TGA will need to meet the higher evidentiary requirements of a Class III medical device.

Patient implant cards and consumer device information leaflets

• Patient implant cards and consumer device information leaflets
  From 1 December 2018, manufacturers of all new permanently implantable devices (other than those exempted) will need to provide patient implant cards and have a consumer device information leaflet, as part of new consumer information requirements.

Pre-market assessment of medical devices reforms

The TGA is implementing a series of medical device regulatory reforms increasing the rigour of pre-market assessment of higher risk medical devices, to assure the quality, safety and performance of these devices.

Further information on key reforms is available from:

• Reclassification of hip, knee and shoulder joint replacements
• Australian medical device manufacturers
• Increased scrutiny of medical devices
• Product names
• Regulation impact statement: Premarket assessment requirements for Australian manufactured medical devices

IVD medical devices reforms

Extension to the timeframe for the transition to the IVD regulatory framework

The current regulatory framework for in vitro diagnostic medical devices (IVDs) was introduced in 2010 via amendments to the Therapeutic Goods (Medical Devices) Regulations 2002 and the Therapeutic Goods Regulations 1990. The provisions included a 4-year transition period for IVDs supplied in Australia prior to 1 July 2010, with all such IVDs required to comply with the new requirements by 1 July 2014.

Due to difficulties encountered during the transition period, the TGA proposed an extension to the timeframe. An extension has now been made through amendments to those regulations. The new deadlines to demonstrate compliance with the IVD regulatory framework are summarised in the table below. They will come into effect immediately before 1 July 2014.

The new transitional provisions do not apply to any product that was supplied prior to 1 July 2010 and since this date, has been the subject of an application for inclusion in the Australian Register of Therapeutic Goods (ARTG) under Chapter 4 of the Therapeutic Goods Act 1989 that was rejected. These products cannot be legally supplied after 30 June 2014 unless they are included in the ARTG.

There is no annual charge for IVDs included in the ARTG under Chapter 4 of the Act for the 2013-2014 financial year. This exemption will continue to the end of the 2016-2017 financial year when the transition period ends.

1. An application is considered to be effective once the prescribed application fee has been paid.

If you require further information on the timeframe extension please email, devicereforms@tga.gov.au.